Have a feature idea you'd love to see implemented? Let us know!

NRC National Research Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: NRC

Price (delayed)

$16.28

Market cap

$382.19M

P/E Ratio

14.41

Dividend/share

$0.48

EPS

$1.13

Enterprise value

$432.36M

NRC Health is the leading provider of in-depth customer insights in healthcare.

Highlights
The stock's price to earnings (P/E) is 53% less than its 5-year quarterly average of 30.6 and 44% less than its last 4 quarters average of 25.6
The quick ratio has grown by 43% since the previous quarter but it has declined by 27% year-on-year
National Research's debt has surged by 125% YoY and by 27% QoQ
National Research's equity has decreased by 40% YoY and by 14% QoQ
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://nrchealth.com
Peers: OMIC NWBO

Key stats

What are the main financial stats of NRC
Market
Shares outstanding
23.48M
Market cap
$382.19M
Enterprise value
$432.36M
Valuations
Price to earnings (P/E)
14.41
Price to book (P/B)
11.22
Price to sales (P/S)
2.68
EV/EBIT
11.56
EV/EBITDA
9.97
EV/Sales
3
Earnings
Revenue
$144.15M
Gross profit
$87.78M
Operating income
$37.31M
Net income
$27.08M
EBIT
$37.42M
EBITDA
$43.35M
Free cash flow
$25.18M
Per share
EPS
$1.13
EPS diluted
$1.13
Free cash flow per share
$1.06
Book value per share
$1.45
Revenue per share
$6.08
TBVPS
$2.65
Balance sheet
Total assets
$131.8M
Total liabilities
$97.18M
Debt
$53.63M
Equity
$34.62M
Working capital
-$23.58M
Liquidity
Debt to equity
1.55
Current ratio
0.47
Quick ratio
0.33
Net debt/EBITDA
1.16
Margins
EBITDA margin
30.1%
Gross margin
60.9%
Net margin
18.8%
Operating margin
25.9%
Efficiency
Return on assets
21.9%
Return on equity
67.4%
Return on invested capital
67%
Return on capital employed
42.8%
Return on sales
26%
Dividend
Dividend yield
2.95%
DPS
$0.48
Payout ratio
42.5%

NRC stock price

How has the National Research stock price performed over time
Intraday
-0.49%
1 week
-1.39%
1 month
-8.18%
1 year
-56.01%
YTD
-7.71%
QTD
-7.71%

Financial performance

How have National Research's revenue and profit performed over time
Revenue
$144.15M
Gross profit
$87.78M
Operating income
$37.31M
Net income
$27.08M
Gross margin
60.9%
Net margin
18.8%
NRC's operating income is down by 8% YoY and by 5% QoQ
NRC's net income is down by 7% QoQ and by 6% YoY
National Research's net margin has decreased by 6% QoQ and by 2.6% YoY
National Research's operating margin has decreased by 5% YoY and by 3.7% QoQ

Growth

What is National Research's growth rate over time

Valuation

What is National Research stock price valuation
NRC P/E details
P/E
14.41
P/B
11.22
P/S
2.68
EV/EBIT
11.56
EV/EBITDA
9.97
EV/Sales
3
The stock's price to earnings (P/E) is 53% less than its 5-year quarterly average of 30.6 and 44% less than its last 4 quarters average of 25.6
The EPS has declined by 7% since the previous quarter and by 3.4% year-on-year
NRC's price to book (P/B) is 40% less than its last 4 quarters average of 18.7 and 36% less than its 5-year quarterly average of 17.6
National Research's equity has decreased by 40% YoY and by 14% QoQ
The P/S is 63% lower than the 5-year quarterly average of 7.2 and 47% lower than the last 4 quarters average of 5.1
National Research's revenue has decreased by 3.1% YoY

Efficiency

How efficient is National Research business performance
NRC's return on equity has surged by 66% year-on-year and by 6% since the previous quarter
NRC's return on invested capital is down by 42% year-on-year and by 19% since the previous quarter
The return on assets has declined by 10% since the previous quarter
The return on sales has declined by 4.1% since the previous quarter

Dividends

What is NRC's dividend history
Dividend details
DPS
$0.48
Dividend yield
2.95%
Payout ratio
42.5%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did National Research financials performed over time
NRC's total assets is 36% greater than its total liabilities
National Research's total liabilities has surged by 56% YoY and by 23% QoQ
The quick ratio has grown by 43% since the previous quarter but it has declined by 27% year-on-year
National Research's debt is 55% higher than its equity
National Research's debt has surged by 125% YoY and by 27% QoQ
NRC's debt to equity is up by 48% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.